1. Home
  2. PSTV vs NURO Comparison

PSTV vs NURO Comparison

Compare PSTV & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • NURO
  • Stock Information
  • Founded
  • PSTV 1996
  • NURO 1996
  • Country
  • PSTV United States
  • NURO United States
  • Employees
  • PSTV N/A
  • NURO N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • NURO Medical/Dental Instruments
  • Sector
  • PSTV Health Care
  • NURO Health Care
  • Exchange
  • PSTV Nasdaq
  • NURO Nasdaq
  • Market Cap
  • PSTV 9.9M
  • NURO 7.3M
  • IPO Year
  • PSTV N/A
  • NURO N/A
  • Fundamental
  • Price
  • PSTV $1.75
  • NURO $3.57
  • Analyst Decision
  • PSTV Strong Buy
  • NURO
  • Analyst Count
  • PSTV 1
  • NURO 0
  • Target Price
  • PSTV $8.00
  • NURO N/A
  • AVG Volume (30 Days)
  • PSTV 59.7K
  • NURO 6.9K
  • Earning Date
  • PSTV 08-12-2024
  • NURO 07-29-2024
  • Dividend Yield
  • PSTV N/A
  • NURO N/A
  • EPS Growth
  • PSTV N/A
  • NURO N/A
  • EPS
  • PSTV N/A
  • NURO N/A
  • Revenue
  • PSTV $6,084,000.00
  • NURO $5,270,210.00
  • Revenue This Year
  • PSTV $5.21
  • NURO N/A
  • Revenue Next Year
  • PSTV N/A
  • NURO N/A
  • P/E Ratio
  • PSTV N/A
  • NURO N/A
  • Revenue Growth
  • PSTV 733.42
  • NURO N/A
  • 52 Week Low
  • PSTV $0.97
  • NURO $2.70
  • 52 Week High
  • PSTV $3.21
  • NURO $7.92
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 47.92
  • NURO 40.98
  • Support Level
  • PSTV $1.62
  • NURO $3.65
  • Resistance Level
  • PSTV $1.92
  • NURO $3.80
  • Average True Range (ATR)
  • PSTV 0.17
  • NURO 0.16
  • MACD
  • PSTV 0.03
  • NURO 0.00
  • Stochastic Oscillator
  • PSTV 52.24
  • NURO 12.35

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Share on Social Networks: